Trial Profile
A Phase Iiib, Open-label, Randomized, Multi-center Study Of The Efficacy And Safety Of Anidulafungin Vs. Fluconazole, In The Treatment Of Subjects With Candidemia And/or Other Forms Of Invasive Candidiasis
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 Sep 2015
Price :
$35
*
At a glance
- Drugs Anidulafungin (Primary) ; Fluconazole; Fluconazole
- Indications Candidaemia; Invasive candidiasis
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 17 Apr 2014 New trial record
- 12 Jan 2012
- 01 Feb 2011